Dr. Gary Heng-Liang Lin is currently working for Fu Jen Catholic University Hospital as a Director of Department of Fund Management, Deputy Director of Center for Innovation and General Secretary of Cell Therapy Group. Dr. Lin has academic experiences at Institute of Biotechnology and Pharmaceutical Research, National Health Research Institute (NHRI) and been focusing on occlusive/ hemorrhage strokes, Idiopathic thrombocytopenic purpura, diabetic nephropathy, myocarditis and polycystic kidney disease-related aneurysm. Dr. Gary Heng-Liang Lin received his Ph.D in 2001 from National Yang-Ming University, Taiwan.
Dr. Gary research interests includes Drug and Med-tech repurposing, Clinical trial design, Translational research, Chemotherapy/ radiation related neuropathic pain (ICD G62.0/ G62.9/ D49.9) Malignant fatigue (thrombocytopenia/ purpura) (ICD R53.0), Mechanism of botanical-derived medicines, Specialty pharmaceutical formulation, Lyophilized technologies for PRP, antibody, stem cells derived factors.
Dr. Alan Goldhamer is the founder of TrueNorth Health Center, a state-of-the-art facility that provides medical and chiropractic services, psychotherapy and counseling, as well as massage and body work. He is also director of the Center's groundbreaking residential health education program. Articulate, inspiring and energetic, Dr. Goldhamer is one of the most pioneering and dedicated visionaries in health today. An outspoken professional who doesn't shy away from a spirited debate, he is deeply committed to helping people stuck in self-destructive cycles reclaim their ability to change their lives. Dr. Goldhamer has supervised the fasts of thousands of patients. Under his guidance, the Center has become one of the premier training facilities for doctors wishing to gain certification in the supervision of therapeutic fasting. Currently, Dr. Goldhamer is directing a team that is developing a prospective study, incorporating random assignment and long-term follow-up on the cost and clinical outcomes in the treatment of diabetes and high blood pressure with fasting and a health-promoting diet. After completing his chiropractic education at Western States Chiropractic College in Portland, Oregon, Dr. Goldhamer traveled to Australia, where he became licensed as an osteopathic physician. He is the author of The Health Promoting Cookbook and co-author of The Pleasure Trap: Mastering The Hidden Force That Undermines Health and Happiness.
Ignacio Quiles MSc, MBA, Ph.D., has 19+ years of managerial biopharmaceutical experience, including 6+ years at the biomedicine research level. My international experience covers the whole value chain from early discovery strategies through clinical development, go-to-market to commercialization, and reimbursement for cancer solutions. I had proudly led strategic businesses in Europe, North America, Canada, Japan, and Latin America. It seriously scaled my apprenticeship from talented and diverse people. These multicultural shocks and the executive trainings were capital in defining my learning agility and strategic thinking. Thanks to all of them, I can drive a better understanding of complex ecosystems, adequate outcome approaches and pursue innovative next-level collaborative solutions aim to serve patients in urgent needs.
Wieslaw Swietnicki is a Biochemist/Molecular Biologist working on bacterial virulence systems. , for human pathogens. His work involves a lot of bioinformatics and computational chemistry methods to design small molecules blocking vital components of pathogens’ metabolism. For vaccines, his work involves a lot of synthetic and systems biology as tools to design next generation of bacterial vaccines. His professional achievements are Vaccine design, 2nd best project in Poland, OPUS 11, Immunology and infectious Diseases, Therapeutics design, Top 3 projects in BioMed, Wroclaw, PL, 2012 and Top 3 projects by Defense Threat Reduction Agency, USA, 2012. His skills are Computer-Aided Drug Discovery, Synthetic Biology, Protein Expression and Purification and Enzyme Kinetics.
Dr. Fuhr has 30+ years of experience in teaching and research. He is Professor of Economics at Widener University. Dr. Fuhr’s primary research areas are antitrust, health economics, pharmacoeconomics, telecommunications, and sports economics. He has published over forty journal articles. In health care, he has written on hospital mergers, exclusive arrangements, health insurance, bundling and doctor’s fees. In pharmacoeconomics, Dr. Fuhr has written on cost benefit analysis and predictive modeling. Dr. Fuhr’s primary research areas are antitrust, health economics, pharmacoeconomics, telecommunications, and sports economics.
PhD (Specialist in Genetic Toxicology; Univ. Autónoma de Barcelona) and Bachelor of Pharmacy (Univ. Central de las Villas, Cuba). Current position: Senior Toxicologist & Nonclinical Safety Adviser, at Ferrer Advanced Biotherapeutics. Ferrer Internacional. Previous positions: Pharmacovigilance Officer/Senior Nonclinical Toxicologist (Ferrer); Medical Adviser. Dermatology Area (Ferrer); Senior Toxicologist. Head of In vivo Toxicology Group (Ferrer); Senior Nonclinical Toxicology Study Director (RCC-CIDA s.a.l.). Senior Toxicologist/Nonclinical Safety with more than 15 years of experience working in the design and management of several fields of nonclinical toxicology and safety issues to support the efficacy/safety in the R&D in New Development Projects with the aim to obtain new medicinal products. Co-author of over 12 peer-review of scientific publications. Invited Speaker at 20 Scientific Events in the last 10 years at international congress. Expert of European Commission: Sixth and Seven Framework Programme. Area Preclinical Toxicology and Mutagenesis. Expert Member Panel in Innovative Medicines Initiative (IMI)-Scientific Panel to evaluate the proposals for the IMI2 9th Call: topic on ‘Next generation of electronic translational safety–NexGETS. Member of Editorial Board of scientific journals and several Organizing Committee of Scientific Congress. Member of Jury several doctoral theses (Univ. Autónoma de Barcelona. Current interests: Open innovation & Collaborative Bio-Research. Advanced Therapies. Neuropharmacology. Ophthalmology. Molecular diagnostics and other Therapeutic areas.
Academician Victor S. Dorodny is the Founder and Chief Scientist of the Naturopathic Evidence-based Wellness (NEW™) Institute in Malibu, California. Prof. Dorodny is dedicated to education of wellness consumers, and implementation his principles of complementary convergence of Naturopathy and traditional Medical Science to achieve and maintain Natural Health. He is the former Chief Medical Officer of the Malibu Medical Reserve Corpse (MMRC)—a volunteer organization under the guidance of the US Surgeon General dedicated to assisting authorities in a form of Medical Disaster Assistance Teams. (MDAT) He is the past Vice-President, of ICN Eastern Europe, a Division of ICN Pharmaceuticals, Inc, Costa Mesa-based global pharmaceutical company and has many years of experience in pharmaceutical, vitamins and nutraceutical manufacturing. As practicing/consulting physician, academician and technologist with 30 years of clinical and consulting experience he is an expert on Anesthesiology and Pain Management, Rehabilitation, and Multi-disciplinary approach to the management of chronic disease states. Academicia Dorodny’s areas of expertise encompass traditional medical practice and naturopathy with a focus on nutrition, botanical medicine, homeopathy, hydrotherapy, physical manipulation, pharmacology and psychology. Dorodny was founder and president of Health PRO Worldwide, Inc., a Health & Wellness consulting company in Pasadena, California since 1993. Since 1995 he is the Founder & Chairman of TRIPAC, National Health & Wellness Advocacy dedicated to ongoing transformation of health consumers and provider of health & wellness products and services, and team approach to utilization of traditional medicine and naturopathic strategies for optimal health. He has served as consultant to the Economic and Social Council of the United Nations; Technical Advisor to the United States Department of Justice and FBI; past president of the National Association of Managed Care Physicians (NAMCP). He is a Board Member of Association of Medical Directors of Information Systems (AMDIS); Board member of the IPA Association of America (TIPAAA), National Managed Health Care Congress/Health Information Technologies (NMHCC/HIT); California State Pharmacy Partnership; Health Care Advisory Committee-Assembly; California Legislature and US Congress. Member(A) of the Scientific Advisory Board of the US Food and Drug Administration (US FDA). A native of Odessa, USSR Prof. Dorodny received his M.D. and M.P.H. degrees from N.I. Pirogov Medical Institute in Odessa, USSR in 1975; He completed his residency in Anesthesiology at the USC-Los Angeles County Medical Center in 1982. Graduate USC Executive Management Institute in Health Care in 1993 and received Ph.D. in Health Informatics from International Informatization Academy in 1997. Prof. Dorodny is Board Certified by the American Academy of Pain Management, and is an Associate in Medicine of the American College of Legal Medicine (ACLM). Prof. Dorodny has made significant contributions to major mass media publications, peer review journals and trade publications. He has authored numerous monographs and books, and his editorial board appointments include Managed Healthcare, and The Medical Reporter. He is the only physician in the USA on the editorial boards of US Pharmacist and Information Security Journal. He is a frequently invited keynote presenter at national and international conferences, and featured guest on national TV and radio. Prof. Dorodny is an Active Academician with the International Informatization Academy (IIA) and a frequent participant in projects at the Institute for Alternative Futures, National Association of Consulting Pharmacist, and Joint Commission for Accreditation of Hospital Organizations (JCAHO), National Pharmaceutical Council, and US Food and Drug Administration.
Dr. Niranjan Koirala, Nepal born researcher earned his Ph.D. from South Korea (2016) and Postdoctoral fellowships from UNAM, Mexico (2018) and UM, Macau SAR (2020). His interest is in the field of pharmaceutical engineering, pharmaceutical/medicinal chemistry, natural products drugs discovery, secondary metabolites, flavonoids, diabetes, antibiotics and anti-cancer agents. He is the recipient of Nepal Bidhya Bhushan “A” award from the honorable President of Nepal, young scientist award, best PhD thesis gold medal award, best oral presentations, best poster presentations and several other research accolades. He has published above 35 original articles in reputed peer-reviewed journals and holds 4 Korean patents. He has a cumulative impact factor of 75, global citations of 700 and h-index 14 as of 2020. He is serving in several national and International indexed journals as the journal editor and editorial board member.